Psychedelic Safety Checklist: Before, During, and After
What to check about a retreat or licensed session before you book, on the day and afterwards: licence, screening, staff, emergency plan, consent, the law and aftercare.
A good retreat or licensed session is mostly decided before you arrive. This checklist covers what to check about the provider, yourself, the place and the aftercare. It does not repeat the medical questions: start with the screening checklist, which covers heart, mental health, medicines and pregnancy with the source behind each question, and the interaction checker if you take any medicine. Come back here once you know that a session is medically reasonable for you.
Why you have to check for yourself
In most places nobody inspects a psychedelic ceremony. The Dutch Trimbos Institute notes that no one checks whether ceremony guidance is in order, including intake, aftercare or the number of sober people present. (DRUGSinfo (Drugs Infolijn), Trimbos-instituut) The exceptions are regulated programmes such as Oregon's licensed psilocybin services and Colorado's licensed healing centres. (Oregon Health Authority, current page; Colorado General Assembly, 23 May 2023; Colorado Department of Revenue, Natural Medicine Division, 2 Apr 2025) Where no regulator checks, every item below is your job.
The provider: before you pay a deposit
Licence and legal standing
- Is there a licence, and from whom? In Oregon, facilitators and service centres are licensed by the Oregon Health Authority, and psilocybin may only be taken at a licensed centre under a facilitator. (Oregon Health Authority, current page; Oregon State Legislature, current edition) Colorado licenses facilitators and healing centres separately. (Colorado General Assembly, 23 May 2023; Colorado General Assembly, 23 May 2023; Colorado Lawyer (Colorado Bar Association)) Outside such programmes, ask what legal basis the centre claims, then check it against is it legal where I am?
- Ibogaine: New Zealand treats it as a prescription-only, unapproved medicine. (Medsafe, New Zealand Ministry of Health, 2009; New Zealand Health and Disability Commissioner, 2015) In Mexico no official standard sets ibogaine-specific safety protocols such as cardiac monitoring. (Infobae Mexico, 21 Sep 2026) Read ibogaine clinic safety before booking any clinic.
Medical screening, and who reviews it
- Does screening happen before payment, and who reads it? A form that nobody medically qualified reviews is paperwork, not screening.
- For ibogaine, an ECG, and potassium and magnesium checks are the minimum. The Global Ibogaine Therapy Alliance guidelines exclude a prolonged QTc and say a QTc over 500 ms during treatment requires immediate hospital transfer. (Global Ibogaine Therapy Alliance (Internet Archive copy), 2016)
- For ayahuasca, ask how the centre handles antidepressants. Combining ayahuasca with an SSRI may cause serotonin syndrome, and stopping a psychiatric medicine is itself risky and should only happen under strict medical supervision. (Journal of Psychoactive Drugs, 1998; ICEERS, 2026; ICEERS, 2018) The details are in ayahuasca and antidepressants. A centre that tells you to stop a medicine on its own timetable is a red flag; that decision belongs to your prescriber.
Staff and training
- Who is trained, in what, and by whom? Oregon facilitators must complete approved training with modules on safety and ethics plus a practicum, pass an exam set by the Oregon Health Authority and pass a background check. (Oregon Health Authority, Public Health Division, May 2025) Elsewhere, ask for names and qualifications.
- How many sober staff are present per participant? Oregon sets minimum client-to-facilitator ratios for group sessions. (Oregon Health Authority, Public Health Division, May 2025) Ask for the number, not a reassurance.
- Is a doctor or nurse on site? For ibogaine this is essential. New Zealand's Health and Disability Commissioner found a clinic in breach after a woman died when her doctor left and monitoring was left to an untrained assistant. (New Zealand Health and Disability Commissioner, 2015)
Emergency plan
- What happens if someone has a medical or psychiatric crisis? In Oregon, facilitators must call emergency services in a medical or behavioural emergency, document it and notify the regulator. (Oregon Health Authority, Public Health Division, May 2025) Emergency services were called 13 times for 5,935 clients in 2025. (Oregon Health Authority, 2026) Rare is not never.
- Where is the nearest hospital, and how would you get there? Remote jungle retreats can be hours away.
- Is there a written plan for you? Oregon requires every client to complete a safety and support plan and a transportation plan. (Oregon Health Authority, Public Health Division, May 2025)
Consent, touch and conduct
- Written consent. The New Zealand ibogaine death involved a clinic that obtained no written consent. (New Zealand Health and Disability Commissioner, 2015)
- A clear touch policy. Oregon's rules limit the kinds of supportive touch allowed and require clients to consent to it before the session. (Oregon Health Authority, Public Health Division, May 2025) Chacruna warns that sessions alone with a healer have been a common setting for sexual abuse, that plant baths and similar practices do not involve touching private parts or require nudity, and that sexual contact between healer and participant during or directly after ceremonies is not acceptable in ayahuasca traditions. (Chacruna Institute for Psychedelic Plant Medicines, 2018)
- A right to stop. You should be able to leave the programme, decline a dose or choose a different facilitator. Oregon's client bill of rights includes choosing your facilitator. (Oregon Health Authority, Public Health Division, May 2025)
- What else is served? Ask for a full list of every substance on the programme. Deaths linked to ayahuasca have involved tobacco preparations and 5-MeO-DMT taken alongside it. (ICEERS, 2023; Journal of Analytical Toxicology, 2005)
Yourself
The screening checklist has the medical questions. Beyond those:
- Tell the provider everything, including supplements and recreational drugs. If they do not ask, that tells you about their screening.
- Do not change any medicine without your prescriber. If a provider says you must, take that conversation to the person who prescribed it.
- Arrange support at home for the days after, and keep the week after free of big commitments.
- Know your reasons. Dutch drug information services say ceremonies advertised as treatment for mental health problems are not therapy and that many people have more complaints afterwards. (DRUGSinfo (Drugs Infolijn), Trimbos-instituut) If you want treatment, look at conditions and clinical trials.
The place and the law
A retreat advertising openly tells you nothing certain about its legal position. Psilocybin is in Schedule I of the 1971 Convention on Psychotropic Substances, and other active ingredients are controlled too. (Transnational Institute (copy of statute), 2001; Instituto Costarricense sobre Drogas, current page; International Narcotics Control Board, Mar 2011) The plants and brews themselves are not under international control, but the International Narcotics Control Board recommends that governments control them nationally where necessary, so international non-control does not mean national legality. (International Narcotics Control Board, Mar 2011) Some examples of how differently countries handle this:
- Portugal makes personal possession an administrative offence, not a crime, but that does not cover a retreat supplying psilocybin to guests. (Diario da Republica, I Serie-A, n.o 276, 29 Nov 2000; Policia Judiciaria, current page)
- Brazil restricts ayahuasca to religious rituals and prohibits selling it. (Ministerio da Justica e Seguranca Publica / Diario Oficial da Uniao, 25 Jan 2010)
- Mexico's non-prosecution rule for mushrooms covers possession tied to Indigenous and Afro-Mexican community ceremonies, not retreats run for visitors. (Camara de Diputados del H. Congreso de la Union, 13 Mar 2026)
The legal status page covers each country. Wild peyote is not on offer here: it is Vulnerable, it is the Native American Church's sacrament, and the site points mescaline interest to cultivated San Pedro instead. See the peyote position. (IUCN Red List, 2017; eCFR, current)
Red flags that should end the conversation
Some answers are enough on their own to walk away:
- A deposit is taken before any medical questions are asked.
- You are told to stop a prescribed medicine, or to taper it on the centre's schedule, without your prescriber.
- Nobody can tell you who is medically responsible during the session, or how they would reach a hospital.
- Ibogaine is offered without an ECG, blood tests and continuous monitoring. A review of 19 deaths after ibogaine found pre-existing heart conditions or other drugs explained or contributed to 12 of the 14 with adequate post-mortem data. (Journal of Forensic Sciences, 2012)
- Ayahuasca is combined in the same programme with toad medicine (5-MeO-DMT), a pairing linked to deaths. (Journal of Analytical Toxicology, 2005; ICEERS, 2023)
- Private sessions alone with a healer, nudity or sexual contact are presented as part of the healing. (Chacruna Institute for Psychedelic Plant Medicines, 2018)
- The programme promises to cure depression, addiction or trauma. No psilocybin medicine is FDA approved, and retreats do not necessarily reproduce the screening and monitoring of clinical trials. (eCFR (Office of the Federal Register), current; U.S. Food and Drug Administration, Jul 2026; Psychiatry Research, 2024)
On the day
- Confirm the screening was read. Ask who reviewed it and whether anything changed.
- Check the room. Oregon requires administration areas to be free of conditions that could pose a risk to clients. (Oregon Health Authority, Public Health Division, May 2025) Look for stairs, water and open fires.
- Drink sensibly. One ayahuasca ceremony death was due to low blood sodium from overhydration. (Nederlands Tijdschrift voor Geneeskunde, 2020; ICEERS, 2023)
- Do not leave alone or drive. Oregon requires a transportation plan for every client. (Oregon Health Authority, Public Health Division, May 2025)
After the session
Integration
Oregon requires facilitators to contact each client within 72 hours of the session to review the safety plan, record any reactions and offer optional integration sessions. (Oregon Health Authority, Public Health Division, May 2025) Ask any provider what follow-up they offer, and who you can call a week later. The integration practices article covers what that work looks like.
Warning signs
Hard days after a session are common. In the Global Ayahuasca Survey, 55.9% reported adverse mental health effects in the following weeks or months; most saw them as part of a positive process, but around 12% sought professional support. (PLOS Global Public Health, 2022) Get help if you notice:
- distress that is not easing after a week or two; in one survey 7.6% of people sought treatment for lasting symptoms after a difficult mushroom experience (Journal of Psychopharmacology, 2016)
- little sleep with racing thoughts or unusual energy; in people with bipolar disorder, mania and sleep problems were the most common new symptoms after psilocybin (Journal of Psychopharmacology, 2023)
- visual effects that keep returning and cause distress, a pattern described as hallucinogen persisting perception disorder (Drug and Alcohol Dependence (Halpern JH, Pope HG), 2003)
- thoughts of harming yourself or anyone else: in the US call or text 988, elsewhere your local emergency number
- after ibogaine for opioid dependence, any plan to use opioids again: tolerance is reset, so a usual dose can be an overdose (Global Ibogaine Therapy Alliance (Internet Archive copy), 2016)
If any of these apply, see a doctor and tell them what you took.
Featured partner
If you are weighing a retreat, Rythmia offers ayahuasca in Costa Rica and is a Peyote.com partner.
Related
- Harm Reduction Basics: A Practical Guide to Safer Use
- Set and Setting: The Most Important Variables in a Psychedelic Experience
- Drug Interaction Warnings: Psychedelics and Medications
Questions and answers
- What should I ask a psychedelic retreat before booking?
- Ask who reviews your medical screening and when, how many sober trained staff are present per participant, whether a doctor or nurse is on site, what the emergency plan is and how far the hospital is, what the touch and consent policy is, and every substance on the programme. Nobody checks most ceremonies, so these answers are your only quality control.Source: DRUGSinfo (Drugs Infolijn), Trimbos-instituutPre-retreat screening checklist
- Do psychedelic facilitators need a licence?
- Only where a regulated programme exists. In Oregon, facilitators must complete approved training with a practicum, pass a state exam and a background check, and psilocybin may only be taken at a licensed service centre. Colorado licenses facilitators and healing centres. Most retreats abroad have no comparable facilitator licence.Sources: Oregon Health Authority, Public Health Division, May 2025; Oregon State Legislature, current edition; Colorado General Assembly, 23 May 2023; Colorado General Assembly, 23 May 2023; Colorado Lawyer (Colorado Bar Association)
- Can a facilitator touch me during a psychedelic session?
- Only with your agreement, and within limits. Oregon's rules restrict the kinds of supportive touch and require the client's consent before the session. Chacruna's community guide says traditional practices such as plant baths do not involve touching private parts or require nudity, and that sexual contact between healer and participant during or after ceremonies is not acceptable.Sources: Oregon Health Authority, Public Health Division, May 2025; Chacruna Institute for Psychedelic Plant Medicines, 2018
- Is it normal to feel worse after a psychedelic retreat?
- Difficult weeks afterwards are common: 55.9% of Global Ayahuasca Survey respondents reported adverse mental health effects, and around 12% of them sought professional support. Distress that is not easing, mania or sleeplessness, or thoughts of self-harm are reasons to see a doctor; in the US, 988 is the crisis line.Source: PLOS Global Public Health, 2022
Sources
- Paddo's: Risico's. DRUGSinfo (Drugs Infolijn), Trimbos-instituut
- Oregon Psilocybin Services: Health and Safety (fact sheet). Oregon Health Authority, Public Health Division, May 2025
- Report of the International Narcotics Control Board for 2010 (paras 284-287). International Narcotics Control Board, Mar 2011
- Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS Global Public Health, 2022
- Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption. Journal of Psychopharmacology, 2023
- Oregon Psilocybin Services. Oregon Health Authority, current page
- Senate Bill 23-290 (signed act). Colorado General Assembly, 23 May 2023
- The DOR's Natural Medicine Division issues Colorado's first healing center license. Colorado Department of Revenue, Natural Medicine Division, 2 Apr 2025
- ORS Chapter 475A - Psilocybin. Oregon State Legislature, current edition
- SB23-290 Natural Medicine Regulation And Legalization. Colorado General Assembly, 23 May 2023
- Colorado's Bold Move to Legalize Psychedelics. Colorado Lawyer (Colorado Bar Association)
- Medicines Classification Committee, Minutes of the 42nd Meeting (3 November 2009), item 10.1 Ibogaine and its metabolite noribogaine. Medsafe, New Zealand Ministry of Health, 2009
- Monitoring of patient following administration of an unapproved, prescription-only medication (13HDC00966). New Zealand Health and Disability Commissioner, 2015
- Que es la ibogaina, la sustancia psicodelica .... Infobae Mexico, 21 Sep 2026
- Clinical Guidelines for Ibogaine-Assisted Detoxification, 1st Edition, Version 1.1. Global Ibogaine Therapy Alliance (Internet Archive copy), 2016
- Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions. Journal of Psychoactive Drugs, 1998
- Ayahuasca Safety Profile. ICEERS, 2026
- Deciding to Take Ayahuasca. ICEERS, 2018
- Oregon Psilocybin Services 2025 Year-End Data Summary Document. Oregon Health Authority, 2026
- Ayahuasca Community Guide for the Awareness of Sexual Abuse. Chacruna Institute for Psychedelic Plant Medicines, 2018
- Examining the Deaths Misattributed to Ayahuasca. ICEERS, 2023
- A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation. Journal of Analytical Toxicology, 2005
- Ley 8204 (text). Transnational Institute (copy of statute), 2001
- Ley 8204. Instituto Costarricense sobre Drogas, current page
- Lei n.o 30/2000, de 29 de Novembro. Diario da Republica, I Serie-A, n.o 276, 29 Nov 2000
- Cogumelos magicos: Prevencao do consumo de substancias estupefacientes. Policia Judiciaria, current page
- Resolucao No 1, de 25 de janeiro de 2010 (CONAD). Ministerio da Justica e Seguranca Publica / Diario Oficial da Uniao, 25 Jan 2010
- Codigo Penal Federal (texto vigente, ultima reforma DOF 13-03-2026). Camara de Diputados del H. Congreso de la Union, 13 Mar 2026
- Lophophora williamsii (Terry, M.), IUCN Red List of Threatened Species 2017. IUCN Red List, 2017
- 21 CFR 1307.31 - Native American Church. eCFR, current
- Fatalities temporally associated with the ingestion of ibogaine. Journal of Forensic Sciences, 2012
- 21 CFR 1308.11 - Schedule I. eCFR (Office of the Federal Register), current
- Psychedelic Drugs: Considerations for Clinical Investigations (final guidance, July 2026). U.S. Food and Drug Administration, Jul 2026
- Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review. Psychiatry Research, 2024
- [Ayahuasca in the Netherlands: what the doctor should know about its side effects]. Nederlands Tijdschrift voor Geneeskunde, 2020
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology, 2016
- Hallucinogen persisting perception disorder: what do we know after 50 years?. Drug and Alcohol Dependence (Halpern JH, Pope HG), 2003